CYTK
CYTOKINETICS INC
NASDAQ · Healthcare · Biotechnology · US
$62.99
−0.51%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 25.07x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -50.48x
- Price / sales
- 123.41x
- Price / cash flow
- -15.77x
Enterprise value
- Enterprise value
- $8.9B
- EV / sales
- 124.89x
- EV / EBITDA
- -10.78x
- EV / EBIT
- -12.58x
- Market cap
- $8.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026